X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3236) 3236
Book Review (803) 803
Publication (366) 366
Newsletter (20) 20
Book Chapter (12) 12
Conference Proceeding (11) 11
Book / eBook (3) 3
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2629) 2629
humans (2389) 2389
adjuvant temozolomide (1827) 1827
oncology (1827) 1827
radiotherapy (1469) 1469
glioblastoma (1406) 1406
female (1269) 1269
male (1216) 1216
chemotherapy (1066) 1066
middle aged (1041) 1041
cancer (1038) 1038
adult (958) 958
aged (951) 951
temozolomide (940) 940
survival (878) 878
clinical neurology (842) 842
glioblastoma multiforme (824) 824
dacarbazine - analogs & derivatives (780) 780
brain neoplasms - drug therapy (709) 709
prognosis (647) 647
treatment outcome (621) 621
brain neoplasms - pathology (619) 619
gliomas (614) 614
surgery (604) 604
brain neoplasms - therapy (594) 594
concomitant (586) 586
care and treatment (559) 559
malignant glioma (554) 554
tumors (554) 554
glioma (535) 535
glioblastoma - drug therapy (534) 534
medicine & public health (528) 528
dacarbazine - therapeutic use (500) 500
brain neoplasms - mortality (491) 491
radiation-therapy (491) 491
combined modality therapy (473) 473
chemotherapy, adjuvant (464) 464
glioblastoma - therapy (442) 442
antineoplastic agents, alkylating - therapeutic use (433) 433
brain neoplasms - radiotherapy (432) 432
glioblastoma - pathology (429) 429
analysis (411) 411
retrospective studies (401) 401
neurology (394) 394
newly-diagnosed glioblastoma (393) 393
glioblastoma - mortality (391) 391
brain tumors (385) 385
radiation (382) 382
animals (370) 370
radiation therapy (367) 367
research (363) 363
multiforme (359) 359
aged, 80 and over (353) 353
glioblastoma - radiotherapy (335) 335
young adult (327) 327
brain cancer (326) 326
disease-free survival (320) 320
health aspects (309) 309
survival analysis (302) 302
antineoplastic agents - therapeutic use (293) 293
glioblastoma-multiforme (287) 287
cell line, tumor (284) 284
brain neoplasms - surgery (282) 282
survival rate (281) 281
magnetic resonance imaging (273) 273
patients (269) 269
radiology, nuclear medicine & medical imaging (266) 266
brain neoplasms - genetics (264) 264
trial (263) 263
malignant gliomas (259) 259
phase-ii trial (257) 257
phase-ii (256) 256
brain (253) 253
adolescent (248) 248
glioma - drug therapy (248) 248
glioma - pathology (248) 248
antineoplastic combined chemotherapy protocols - therapeutic use (246) 246
clinical trials (244) 244
medical prognosis (244) 244
dacarbazine - administration & dosage (240) 240
neurosciences (240) 240
kaplan-meier estimate (239) 239
therapy (239) 239
radiotherapy, adjuvant (238) 238
brain-tumors (233) 233
follow-up studies (232) 232
glioblastoma - surgery (224) 224
glioblastoma - genetics (220) 220
bevacizumab (218) 218
high-grade gliomas (216) 216
cancer therapies (215) 215
adjuvant chemotherapy (210) 210
apoptosis (208) 208
adjuvant treatment (207) 207
immunotherapy (207) 207
hematology, oncology and palliative medicine (205) 205
neurosurgery (205) 205
prognostic-factors (202) 202
antineoplastic agents (197) 197
expression (197) 197
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3179) 3179
French (39) 39
German (29) 29
Czech (7) 7
Hungarian (4) 4
Chinese (3) 3
Polish (2) 2
Dutch (1) 1
Italian (1) 1
Japanese (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1027 - 1037
Journal Article
CANCER, ISSN 0008-543X, 06/2010, Volume 116, Issue 12, pp. 2868 - 2877
Journal Article
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 582 - 587
Because MET is emerging as a key mediator of resistance to antivascular endothelial growth factor therapy, the vascular endothelial growth factor receptor 2... 
antiangiogenic therapy | glioblastoma | high‐grade glioma | signal transduction inhibitors | cabozantinib | high-grade glioma | CELLS | BEVACIZUMAB | KINASE INHIBITOR | INVASION | ONCOLOGY | POOR-PROGNOSIS | THYROID-CANCER | C-MET | GROWTH-FACTOR | EXPRESSION | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Astrocytoma - therapy | Nausea - chemically induced | Humans | Middle Aged | Brain Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Alanine Transaminase - blood | Fatigue - chemically induced | Neurosurgical Procedures | Astrocytoma - pathology | Neoplasm Grading | Maintenance Chemotherapy - methods | Hypertension - chemically induced | Dacarbazine - analogs & derivatives | Adult | Female | Neutropenia | Chemoradiotherapy - methods | Dacarbazine - administration & dosage | Pyridines - administration & dosage | Leukopenia | Diarrhea | Treatment Outcome | Thrombocytopenia - chemically induced | Chemoradiotherapy, Adjuvant - methods | Constipation - chemically induced | Glioblastoma - therapy | Maximum Tolerated Dose | Anilides - administration & dosage | Aspartate Aminotransferases - blood | L-Lactate Dehydrogenase - blood | Glioblastoma - pathology | Brain Neoplasms - therapy | Aged | Usage | Care and treatment | Gliomas | Dosage and administration | Temozolomide | Diagnosis | Radiotherapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2017, Volume 135, Issue 3, pp. 545 - 552
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2011, Volume 17, Issue 16, pp. 5473 - 5480
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article